Rennova Health, Inc.
RNVA
$0.00
$0.000.00%
09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
---|---|---|---|---|---|
Net Income | -548.20K | -- | 805.60K | 819.90K | -1.34M |
Total Depreciation and Amortization | 56.80K | -- | 94.10K | 117.90K | 117.40K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -328.80K | -- | -563.00K | -823.60K | 127.20K |
Change in Net Operating Assets | 575.80K | -- | 804.60K | 834.10K | 1.14M |
Cash from Operations | -244.50K | -- | 1.14M | 948.20K | 43.60K |
Capital Expenditure | -46.50K | -- | -220.50K | -400.00 | -900.00 |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -131.80K | -- | -313.90K | -363.40K | -77.60K |
Cash from Investing | -178.30K | -- | -534.30K | -363.90K | -78.50K |
Total Debt Issued | 0.00 | -- | 580.00K | 650.00K | -164.70K |
Total Debt Repaid | -178.90K | -- | -1.44M | -534.10K | -41.90K |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | 0.00 | 0.00 |
Issuance of Preferred Stock | -- | -- | -- | 0.00 | 0.00 |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -211.80K | 125.50K |
Cash from Financing | -178.90K | -- | -855.20K | -95.90K | -81.00K |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -601.60K | -- | -248.20K | 488.50K | -115.90K |